Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.

Mario Stampanoni Bassi Ennio IezziDoriana LandiFabrizia MonteleoneLuana GilioIlaria SimonelliAlessandra MusellaGeorgia MandolesiFrancesca De VitoRoberto FurlanAnnamaria FinardiGirolama A MarfiaDiego CentonzeFabio Buttari

Published in: Journal of neurology (2018)

Delayed diagnosis and treatment initiation are associated with higher CSF levels of IL-6 and IL-8 in RR-MS, leading to worsening disease course and poor response to treatments.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
cerebrospinal fluid
current status
replacement therapy